1 Min Read
April 20 (Reuters) - Jounce Therapeutics Inc-
* Jounce Therapeutics initiates phase 2 portion of iconic study of JTX-2011 in patients with advanced solid tumors Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.